Literature DB >> 32167213

Microvasculature partial endothelial mesenchymal transition in early posttransplant biopsy with acute tubular necrosis identifies poor recovery renal allografts.

Yi-Chun Xu-Dubois1,2,3, Pedram Ahmadpoor3, Isabelle Brocheriou4, Kevin Louis1, Nadia Arzouk Snanoudj5, Philippe Rouvier4, Jean-Luc Taupin6,7, Anthony Corchia1, Pierre Galichon1,3, Benoit Barrou5, Sébastien Giraud8,9, Thierry Hauet8,9,10, Chantal Jouanneau1, Anita Rodenas11, Sandrine Placier1, Aissata Niasse1, Souhila Ouchelouche1, Ben-Youssef Naimi12, Elsa Akil12, Alexandre Hertig1,3,5, David Buob1,11, Eric Rondeau1,3.   

Abstract

Acute tubular necrosis (ATN), a frequent histopathological feature in the early post-renal transplant biopsy, affects long-term graft function. Appropriate markers to identify patients at risk of no or incomplete recovery after delayed graft function are lacking. In this study, we first included 41 renal transplant patients whose biopsy for cause during the first month after transplantation showed ATN lesions. Using partial microvasculature endothelial (fascin, vimentin) and tubular epithelial (vimentin) to mesenchymal transition markers, detected by immunohistochemistry, we found a significant association between partial endothelial to mesenchymal transition and poor graft function recovery (Spearman's rho = -0.55, P = .0005). Transforming growth factor-β1 was strongly expressed in these phenotypic changed endothelial cells. Extent of ATN was also correlated with short- and long-term graft dysfunction. However, the association of extensive ATN with long-term graft dysfunction (24 months posttransplant) was observed only in patients with partial endothelial to mesenchymal transition marker expression in their grafts (Spearman's rho = -0.64, P = .003), but not in those without. The association of partial endothelial to mesenchymal transition with worse renal graft outcome was confirmed on 34 other early biopsies with ATN from a second transplant center. Our results suggest that endothelial cell activation at the early phase of renal transplantation plays a detrimental role.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  biomarker; clinical research / practice; delayed graft function (DGF); ischemia/reperfusion injury (IRI); kidney transplantation/nephrology; pathology/histopathology; rejection: antibody-mediated (ABMR); translational research/science; vascular biology

Mesh:

Year:  2020        PMID: 32167213     DOI: 10.1111/ajt.15847

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  3 in total

1.  Notch3 expression in capillary pericytes predicts worse graft outcome in human renal grafts with antibody-mediated rejection.

Authors:  Yichun Xu-Dubois; Panagiotis Kavvadas; Zela Keuylian; Alexandre Hertig; Eric Rondeau; Christos Chatziantoniou
Journal:  J Cell Mol Med       Date:  2022-05-25       Impact factor: 5.295

2.  MiR-126-3p Is Dynamically Regulated in Endothelial-to-Mesenchymal Transition during Fibrosis.

Authors:  Nina P Jordan; Samuel J Tingle; Victoria G Shuttleworth; Katie Cooke; Rachael E Redgrave; Esha Singh; Emily K Glover; Hafiza B Ahmad Tajuddin; John A Kirby; Helen M Arthur; Chris Ward; Neil S Sheerin; Simi Ali
Journal:  Int J Mol Sci       Date:  2021-08-11       Impact factor: 5.923

Review 3.  Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.

Authors:  Marco Quaglia; Guido Merlotti; Gabriele Guglielmetti; Giuseppe Castellano; Vincenzo Cantaluppi
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.